STAT+: Pharmalittle: FDA slams company recalling eye drops over manufacturing issues; U.S. funds massive Alzheimer’s research database
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Category: drug pricing
STAT+: European Union drug pricing proposal for the pandemic treaty generates pushback
Amid treaty talks to create equitable access to medical products during pandemics, the European Union…
STAT+: Inflation caused a sizable drop in net drug prices in late 2022, analysis finds
Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name…
STAT+: Solicitor General urges Supreme Court to review ‘skinny labeling’ and generic drug access
The U.S. solicitor general urged the U.S. Supreme Court to review a controversy over so-called…
STAT+: Dutch health minister won’t cover a Gilead cancer drug due to the cost
In a rare move, the Dutch health ministry refused to provide coverage for a Gilead…
.jpg)
STAT+: Could a fight over cost-effectiveness upend Medicare drug price negotiation before it’s begun?
WASHINGTON — As Medicare drug price negotiation looms, congressional Republicans are scrambling to push through…
STAT+: Ohio attorney general accuses pharmacy benefit managers of drug price fixing
The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers…
STAT+: Bernie Sanders’ accidentally great drug pricing idea
When Moderna CEO Stéphane Bancel was called before a Senate committee last week to defend…
STAT+: J&J loses a patent battle in India over a crucial tuberculosis drug
In a defeat for Johnson & Johnson, the Indian patent office has rejected its bid…
STAT+: Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines
In the face of rising drug prices, health plan sponsors have quietly used a clever,…
Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government
WASHINGTON — Moderna CEO Stéphane Bancel and Senate health committee Chair Bernie Sanders shook hands…
STAT+: NIH rejects bid to cut a cancer drug’s price by sidestepping patents
In a long-awaited decision, the U.S. National Institutes of Health rejected a petition urging the…
STAT+: Sanofi becomes the third leading insulin maker to lower list prices, cutting Lantus price by 78%
Following the lead of its rivals, Sanofi will cut the price of its most widely…
STAT+: Here’s why there aren’t many cheap, generic versions of pricey inhalers
U.S. regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over…
STAT+: Medicare explains how it will choose drugs for negotiation
WASHINGTON — Medicare laid out Thursday in the greatest detail yet how it will choose…
STAT+: Biden administration to fine manufacturers of 27 medicines for price hikes
WASHINGTON — The Biden administration will fine drugmakers who hiked prices faster than the rate…
STAT+: PhRMA chief dings health insurers over drug prices at their own conference
WASHINGTON — The head of the brand drug lobby used an in-person health insurance industry…
STAT+: Novo Nordisk to lower insulin prices by up to 75% amid growing pressure
Under mounting pressure, Novo Nordisk plans to cut U.S. list prices for several insulin products…
STAT+: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
By law, Medicare will have to take a medication’s efficacy and its research and development…
STAT+: Biden makes drug pricing a central part of his deficit reduction plans
WASHINGTON – President Biden made lowering drug prices a key part of his budget with…
STAT+: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment
Now that Eli Lilly is cutting prices on some of its insulin products, U.S. Sen….
STAT+: An unlikely new 340B alliance emerges between PhRMA and community health centers
WASHINGTON — An unusual new alliance of the brand-drug lobby PhRMA and community health centers…
STAT+: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines
WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive…
Science adviser Collins hints at a big White House ask to eliminate hepatitis C
WASHINGTON — The Biden administration will request “significant investments” to help eliminate hepatitis C in…
Biden proposes expanding Medicare drug negotiation program
WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law by allowing…
STAT+: Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye treatment
A Turkish court overturned a decision by the national antitrust regulator that two years ago…
STAT+: Medicare may test policy of paying less for accelerated approval drugs
A Medicare official hinted Tuesday that Medicare might test a policy of paying less for…
STAT+: U.K. lawmakers urge Pfizer not to raise the price of its Covid-19 vaccine
Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine,…
STAT+: Pharma wins a key round in a court battle with hospitals over a drug discount program
In a victory for the pharmaceutical industry, a federal appeals court ruled drug companies have…
STAT+: A bellwether for biosimilars: Why the new competition for Humira matters to pharma, payers, and patients
After months of anticipation, the first biosimilar version of Humira will become available next week…
STAT+: Warren urges the FTC to scrutinize two pharma mergers over “anti-competitive” practices
In her latest bid to address prescription drug prices, U.S. Sen. Elizabeth Warren (D-Mass.) is…
STAT+: The unexpected alliance lobbying for Medicare to pay for new obesity drugs
WASHINGTON — It’s not every day that the pharmaceutical industry, the NAACP, a cancer center, and…
STAT+: Doctors’ group complains that 60 Minutes segment on Wegovy was really just an ad
A physicians’ group has filed a complaint with the U.S. Food and Drug Administration alleging…
STAT+: PhRMA terminates lobbying contract with White House official’s brother
WASHINGTON — The pharmaceutical industry lobbying group PhRMA has severed its contract with a lobbyist who…
STAT+: Despite court ruling, FDA will continue with its approach to approving orphan drug exclusivity
In an unexpected move, the U.S. Food and Drug Administration will continue to apply exclusive…
Opinion: Even with lawsuits and copay caps, will insulin ever be affordable?
In an attempt to tackle the root causes of the inflated cost of insulin, the…
STAT+: For only the second time, a big drugmaker offers a warranty on a medicine
In a bid to blunt competition and address rising drug costs, Sanofi is offering a…
STAT+: Major purchasers predict expensive new therapies will keep driving drug price hikes
More than two dozen big buyers of prescription medicines expect that prices will rise by…
STAT+: Pfizer says it will widen access to hundreds of off-patent medicines in poor countries
In another bid to widen access to its medical products, Pfizer plans to provide roughly…
STAT+: Large health insurers lowered barriers to fair access to some drugs, analysis finds
Most of the largest health plans in the U.S. generally provide “fair access” to 19…
Opinion: Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it
Two congressional committees recently released damning results of an 18-month investigation into the Food and…
STAT+: With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s…
STAT+: HHS will seek more input on its new Medicare drug price negotiations
WASHINGTON — The Department of Health and Human Services is gearing up to start releasing…
STAT+: Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
For the third time in less than a year, a group of lawmakers is urging…
STAT+: Moderna plans to follow in Pfizer’s footsteps, charge up to $130 for Covid-19 vaccine in U.S.
Moderna disclosed Monday that it plans to price its Covid-19 vaccine at anywhere from $110…
STAT+: The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions
Now that the U.S. Food and Drug Administration has granted accelerated approval to the widely…
FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease
The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately…
STAT+: 3 drug pricing issues to watch in 2023
WASHINGTON — The legislative saga on drug pricing is mostly over for now, but drug…
STAT+: ‘Stuck in a rut’: As debate flares over access to medicines, the future of voluntary licensing is up in the air
ANNECY, FRANCE — At first blush, the deal was hailed as a breakthrough. Last fall,…
STAT+: Medicare would have saved $3.7 billion on Part B drugs if inflationary rebates were around in a recent three-year period
If rebates had been required for price hikes on most of the nearly 100 medicines…